Twitter Facebook Flickr YouTube


Uplifting and inspirational plenary sessions at the start of each day.

National Convention 2014
Alan Clayton and Jayne George

Monday 7 July
Proud to be a fundraiser
Alan Clayton, Creative Director, Revolutionise Clayton Burnett
Jayne George, Executive Director of Fundraising and Marketing, Guide Dogs

This is important. Very important. When academics and practitioners examined research and case histories on the subject 'What makes a great fundraising organisation?' they found one succinct, key insight: 'In the great fundraising organisations, the whole organisation was proud of its fundraising, as well as of its mission.'

This is so important that, when you book, you can (and should) bring your CEO or a trustee to this plenary, free of charge.

In order to have much more money to spend on the mission, everybody from the chair of the board to the finance department to service delivery staff and, of course, every single fundraiser needs to be proud of fundraising and the donors who support the mission.

The purpose of this plenary is to give you a tool-kit for 'whole organisation fundraising' to convince and inspire your board, executive team, colleagues and fundraisers to lift your fundraising to a whole new level.

Alan will present the '5Ps' of how to achieve 'whole organisation fundraising.'

More importantly, Jayne will tell you how Guide Dogs (who grew over 20% last year) are achieving it, and what results they are getting.

Bring your CEO or a trustee and your fundraising will never be the same again.

(P.S. 'Great fundraising' was defined as organisations which doubled, tripled or quadrupled their voluntary income over a five to ten year period.)

Harpal S Kumar

Tuesday 8 July
Harpal S Kumar MA MEng MBA DSc
Chief Executive Officer of Cancer Research UK

Harpal Kumar gained a Masters in Chemical Engineering from the University of Cambridge and an MBA as a Baker Scholar from Harvard Business School. He was awarded an Honorary Doctorate from the University of Manchester in October 2011. After a brief period working as a research scientist with the UK Atomic Energy Authority, Harpal worked for four years in the London office of McKinsey and Co, specialising in advising pharmaceutical clients on strategic issues. He then became CEO of The Papworth Trust, which focuses on pioneering rehabilitation and housing services for people with acquired and congenital disabilities.

Harpal left Papworth in 1997 to become founding CEO of Nexan Group, a venture capital-backed medical device company, creating and marketing novel cardio-respiratory monitoring technologies for clinical trials and to reduce premature mortality in patients with congestive heart failure.

Harpal joined Cancer Research Technology Limited (CRT, a wholly-owned subsidiary of Cancer Research UK) as Chief Executive in October 2002 to drive forward the charity's technology transfer and early drug discovery activities. In addition to his role with CRT, he became Chief Operating Officer of Cancer Research UK in July 2004, before becoming Chief Executive in April 2007.

Harpal is a Trustee of the Institute for Cancer Research and the Francis Crick Institute, both in London. He is the Chairman of the Board of the National Cancer Research Institute. He chairs the Cancer Outcomes Strategy Advisory Group in England and co-chairs the National Awareness and Early Diagnosis Initiative.

Loyd Grossman

Wednesday 9 July
Loyd Grossman

Loyd Grossman is an entrepreneur, writer and broadcaster who has had a long involvement with museums and heritage in the UK. A former Commissioner of English Heritage and of the Royal Commission on the Historic Monuments of England, he is Chairman of the Churches Conservation Trust and Chairman of the Heritage Alliance. He is a member of the board of the Association of Leading Visitor Attractions.

Loyd was born in Boston, and educated at Boston University, the London School of Economics and Magdalene College Cambridge. He is an Emeritus Governor of the LSE and a member of the Council of the British School at Rome.